Ertugliflozin

Generic name: Pronounced as (er'' too gli floe' zin)
Brand names
  • Steglatro®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 03/15/2022

Ertugliflozin is used along with diet and exercise, and sometimes with other medications, to lower blood sugar levels in people with type 2 diabetes (condition in which blood sugar is too high because the body does not produce or use insulin normally). Ertugliflozin is in a class of medications called sodium-glucose co-transporter 2 (SGLT2) inhibitors. It lowers blood sugar by causing the kidneys to get rid of more glucose in the urine. Ertugliflozin is not used to treat type 1 diabetes (condition in which the body does not produce insulin and, therefore, cannot control the amount of sugar in the blood) or diabetic ketoacidosis (a serious condition that may develop if high blood sugar is not treated).

Over time, people who have diabetes and high blood sugar can develop serious or life-threatening complications, including heart disease, stroke, kidney problems, nerve damage, and eye problems. Taking medication(s), making lifestyle changes (e.g., diet, exercise, quitting smoking), and regularly checking your blood sugar may help to manage your diabetes and improve your health. This therapy may also decrease your chances of having a heart attack, stroke, or other diabetes-related complications such as kidney failure, nerve damage (numb, cold legs or feet; decreased sexual ability in men and women), eye problems, including changes or loss of vision, or gum disease. Your doctor and other healthcare providers will talk to you about the best way to manage your diabetes.

Ertugliflozin comes as a tablet to take by mouth. It is usually taken once a day in the morning with or without food. Take ertugliflozin at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take ertugliflozin exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Your doctor may start you on a low dose of ertugliflozin and gradually increase your dose.

Ertugliflozin controls type 2 diabetes but does not cure it. Continue to take ertugliflozin even if you feel well. Do not stop taking ertugliflozin without talking to your doctor.

Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with ertugliflozin and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) to obtain the Medication Guide.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking ertugliflozin,

  • tell your doctor and pharmacist if you are allergic (rash, hives, swelling of your face, lips, tongue, or throat, or difficulty breathing) to ertugliflozin, any other medications, or any of the ingredients in ertugliflozin tablets. Ask your pharmacist or check the Medication Guide for a list of the ingredients.

  • tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: diuretics ('water pills'); and insulin or oral medications for diabetes such as chlorpropamide (Diabinese), glimepiride (Amaryl, in Duetact), glipizide (Glucotrol), glyburide (DiaBeta, Glynase), tolazamide, and tolbutamide. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • tell your doctor if you are on dialysis and if you have or have ever had kidney disease. Your doctor may tell you not to take ertugliflozin.

  • tell your doctor if you regularly drink alcohol or sometimes drink large amounts of alcohol in a short time (binge drinking), have ever had an amputation, or are on a low sodium diet. Also, tell your doctor if you have or have ever had low blood pressure, urinary tract infections or urinary problems, pancreatic disease including pancreatitis (swelling of the pancreas) or have had surgery on your pancreas, yeast infections in the genital area, peripheral vascular disease (narrowing of blood vessels in feet, legs, or arms causing numbness, pain, or coldness in that part of the body), neuropathy (nerve damage that causes tingling, numbness, and pain, usually in your hands and feet), foot ulcers or sores, or liver disease. If you are male, tell your doctor if you have never been circumcised. Tell your doctor if you are eating less due to illness, surgery, or a change in your diet or if you are unable to eat or drink normally due to nausea, vomiting, diarrhea, or if you become dehydrated from being in the sun too long.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. Do not breastfeed while you are taking ertugliflozin. If you become pregnant while taking ertugliflozin, call your doctor.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking ertugliflozin.

  • alcohol may cause a change in blood sugar. Ask your doctor about the safe use of alcoholic beverages while you are taking ertugliflozin.

  • you should know that ertugliflozin may cause dizziness, lightheadedness, and fainting when you get up too quickly from a lying position. If you have this problem, call your doctor. To avoid this problem, get out of bed slowly, resting your feet on the floor for a few minutes before standing up.

  • ask your doctor what to do if you get sick, develop an infection or fever, experience unusual stress, or are injured. These conditions can affect your blood sugar and the amount of ertugliflozin you may need.

Be sure to follow all exercise and dietary recommendations made by your doctor or dietitian. It is important to eat a healthful diet.

Follow your doctor's instructions about drinking enough fluids throughout the day while you are on this medication.

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

This medication may cause changes in your blood sugar. You should know the symptoms of low and high blood sugar and what to do if you have these symptoms.

  • Ertugliflozin may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • urinating a lot, including at night

    • increased thirst

    • dry mouth

  • Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately:

    • frequent, urgent, burning, or painful urination

    • decrease in amount of urine

    • urine that is cloudy, red, pink, or brown

    • strong smelling urine

    • pelvic or rectal pain

    • (in women) vaginal odor, white or yellowish vaginal discharge (may be lumpy or look like cottage cheese), or vaginal itching

    • (in men) redness, itching, or swelling of the penis; rash on the penis; foul smelling discharge from the penis; or pain in the skin around the penis

    • feeling tired, weak, or uncomfortable; along with a fever and pain, tenderness, redness, and swelling of the genitals or the area between the genitals and the rectum

    • fever, chills, or other signs of infection

    • pain, tenderness, sores, ulcers, or swollen, warm, reddened area in your leg or foot

  • If you experience any of the following symptoms, stop taking ertugliflozin and call your doctor immediately or get emergency medical treatment:

    • rash

    • hives

    • itching

    • difficulty swallowing

    • swelling of the face, throat, tongue, lips, mouth, or eyes

    • hoarseness

  • If you experience any of the following symptoms of ketoacidosis, stop taking ertugliflozin and call your doctor immediately or get emergency medical treatment. If possible, check for ketones in your urine if you have these symptoms, even if your blood sugar is less than 250 mg/dL:

    • nausea

    • vomiting

    • stomach-area pain

    • tiredness

    • difficulty breathing

  • Ertugliflozin may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Keep all appointments with your doctor and the laboratory. Your doctor will order a lab test before and during your treatment with ertugliflozin to check how well your kidneys are working. Your blood sugar levels should be checked regularly to determine your response to ertugliflozin. Your doctor will order other lab tests, including glycosylated hemoglobin (HbA1c), to check your response to ertugliflozin. Your doctor will also tell you how to check your response to this medication by measuring your blood sugar levels at home. Follow these instructions carefully.

Before having any laboratory test, tell your doctor and the laboratory personnel that you are taking ertugliflozin. Because of the way this medication works, your urine may test positive for glucose.

You should always wear a diabetic identification bracelet to be sure you get proper treatment in an emergency.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

  • Segluromet® (containing Ertugliflozin, Metformin)
  • Steglujan® (containing Ertugliflozin, Sitagliptin)

Drug Interaction
Moxifloxacin Moxifloxacin The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Moxifloxacin.
Repaglinide Repaglinide The therapeutic efficacy of Repaglinide can be increased when used in combination with Ertugliflozin.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection The therapeutic efficacy of Insulin glargine can be increased when used in combination with Ertugliflozin.
Atorvastatin Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Ertugliflozin.
Bisacodyl Bisacodyl The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Bisacodyl.
Cilostazol Cilostazol Ertugliflozin may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy.
Diphenoxylate Diphenoxylate The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Diphenoxylate.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The serum concentration of Ertugliflozin can be increased when it is combined with Erythromycin.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) Ertugliflozin may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.
Fenofibrate Fenofibrate Ertugliflozin may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.
Guanfacine Guanfacine Ertugliflozin may increase the excretion rate of Guanfacine which could result in a lower serum level and potentially a reduction in efficacy.
Magnesium Hydroxide Magnesium Hydroxide The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Magnesium hydroxide.
Magnesium Oxide Magnesium Oxide The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Magnesium oxide.
Miglitol Miglitol The therapeutic efficacy of Miglitol can be increased when used in combination with Ertugliflozin.
Mycophenolate Mycophenolate The metabolism of Mycophenolic acid can be decreased when combined with Ertugliflozin.
Olsalazine Olsalazine Olsalazine may increase the hypoglycemic activities of Ertugliflozin.
Paregoric Paregoric The metabolism of Morphine can be decreased when combined with Ertugliflozin.
Penbutolol Penbutolol The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Acebutolol.
Pentazocine Pentazocine The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Pentazocine.
Polyethylene glycol-electrolyte solution (PEG-ES) Polyethylene glycol-electrolyte solution (PEG-ES) The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Polyethylene glycol.
Potassium Potassium Ertugliflozin may increase the excretion rate of Potassium cation which could result in a lower serum level and potentially a reduction in efficacy.
Prednisone Prednisone The risk or severity of hyperglycemia can be increased when Prednisone is combined with Ertugliflozin.
Psyllium Psyllium The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Plantago seed.
Ranitidine Ranitidine Ertugliflozin may increase the excretion rate of Ranitidine which could result in a lower serum level and potentially a reduction in efficacy.
Reserpine Reserpine The serum concentration of Ertugliflozin can be increased when it is combined with Reserpine.
Rizatriptan Rizatriptan Ertugliflozin may increase the excretion rate of Rizatriptan which could result in a lower serum level and potentially a reduction in efficacy.
Sumatriptan Sumatriptan The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Sumatriptan.
Tacrolimus Tacrolimus The serum concentration of Ertugliflozin can be increased when it is combined with Tacrolimus.
Triamcinolone Triamcinolone The risk or severity of hyperglycemia can be increased when Triamcinolone is combined with Ertugliflozin.
Ampicillin Injection Ampicillin Injection Ertugliflozin may increase the excretion rate of Ampicillin which could result in a lower serum level and potentially a reduction in efficacy.
Doxycycline Injection Doxycycline Injection Ertugliflozin may increase the excretion rate of Doxycycline which could result in a lower serum level and potentially a reduction in efficacy.
Fluconazole Injection Fluconazole Injection The risk or severity of hypoglycemia can be increased when Ertugliflozin is combined with Fluconazole.
Hydromorphone Injection Hydromorphone Injection The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Hydromorphone.
Levofloxacin Injection Levofloxacin Injection The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Levofloxacin.
Meperidine Injection Meperidine Injection Ertugliflozin may increase the excretion rate of Meperidine which could result in a lower serum level and potentially a reduction in efficacy.
Methylprednisolone Injection Methylprednisolone Injection The risk or severity of hyperglycemia can be increased when Methylprednisolone is combined with Ertugliflozin.
Metoclopramide Injection Metoclopramide Injection Ertugliflozin may increase the excretion rate of Metoclopramide which could result in a lower serum level and potentially a reduction in efficacy.
Metronidazole Injection Metronidazole Injection The metabolism of Metronidazole can be decreased when combined with Ertugliflozin.
Morphine Injection Morphine Injection The metabolism of Morphine can be decreased when combined with Ertugliflozin.
Vancomycin Injection Vancomycin Injection Ertugliflozin may increase the excretion rate of Vancomycin which could result in a lower serum level and potentially a reduction in efficacy.
Zidovudine Injection Zidovudine Injection The metabolism of Zidovudine can be decreased when combined with Ertugliflozin.
Altretamine Altretamine Ertugliflozin may increase the excretion rate of Amphetamine which could result in a lower serum level and potentially a reduction in efficacy.
Cyclosporine Cyclosporine The serum concentration of Cyclosporine can be increased when it is combined with Ertugliflozin.
Torsemide Torsemide The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Torasemide.
Olanzapine Olanzapine The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Olanzapine.
Hydroxychloroquine Hydroxychloroquine The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Hydroxychloroquine.
Meloxicam Meloxicam The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Meloxicam.
Pantoprazole Pantoprazole Pantoprazole may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Telmisartan Telmisartan Telmisartan may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Temozolomide Temozolomide Ertugliflozin may increase the excretion rate of Temozolomide which could result in a lower serum level and potentially a reduction in efficacy.
Zaleplon Zaleplon Ertugliflozin may increase the excretion rate of Zaleplon which could result in a lower serum level and potentially a reduction in efficacy.
Linezolid Linezolid Linezolid may increase the hypoglycemic activities of Ertugliflozin.
Trimipramine Trimipramine Trimipramine may decrease the hypoglycemic activities of Ertugliflozin.
Perindopril Perindopril The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Ertugliflozin is combined with Perindopril.
Tenofovir Tenofovir The serum concentration of Tenofovir can be increased when it is combined with Ertugliflozin.
Sirolimus Sirolimus The serum concentration of Sirolimus can be increased when it is combined with Ertugliflozin.
Epinephrine Injection Epinephrine Injection The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Epinephrine.
Escitalopram Escitalopram The risk or severity of hypoglycemia can be increased when Escitalopram is combined with Ertugliflozin.
Zonisamide Zonisamide The metabolism of Zonisamide can be decreased when combined with Ertugliflozin.
Aripiprazole Aripiprazole The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Aripiprazole.
Atomoxetine Atomoxetine Ertugliflozin may increase the excretion rate of Atomoxetine which could result in a lower serum level and potentially a reduction in efficacy.
Ezetimibe Ezetimibe The metabolism of Ezetimibe can be decreased when combined with Ertugliflozin.
Atazanavir Atazanavir The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Atazanavir.
Almotriptan Almotriptan Ertugliflozin may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.
Polyethylene Glycol 3350 Polyethylene Glycol 3350 The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Polyethylene glycol.
Rosuvastatin Rosuvastatin The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Rosuvastatin.
Vardenafil Vardenafil The serum concentration of Ertugliflozin can be increased when it is combined with Vardenafil.
Emtricitabine Emtricitabine Ertugliflozin may increase the excretion rate of Emtricitabine which could result in a lower serum level and potentially a reduction in efficacy.
Memantine Memantine Ertugliflozin may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.
Tegaserod Tegaserod The serum concentration of Ertugliflozin can be increased when it is combined with Tegaserod.
Tadalafil Tadalafil Ertugliflozin may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.
Fosamprenavir Fosamprenavir The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Fosamprenavir.
Gemifloxacin Gemifloxacin The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Gemifloxacin.
Progesterone Progesterone Progesterone may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Oxandrolone Oxandrolone Oxandrolone may increase the hypoglycemic activities of Ertugliflozin.
Protriptyline Protriptyline Protriptyline may decrease the hypoglycemic activities of Ertugliflozin.
Duloxetine Duloxetine The risk or severity of hypoglycemia can be increased when Duloxetine is combined with Ertugliflozin.
Norethindrone Norethindrone The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Norethisterone.
Tinidazole Tinidazole Ertugliflozin may increase the excretion rate of Tinidazole which could result in a lower serum level and potentially a reduction in efficacy.
Bosentan Bosentan The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Bosentan.
Cefditoren Cefditoren Ertugliflozin may increase the excretion rate of Cefdinir which could result in a lower serum level and potentially a reduction in efficacy.
Cyanocobalamin Injection Cyanocobalamin Injection Ertugliflozin may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.
Erlotinib Erlotinib Erlotinib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Eszopiclone Eszopiclone Ertugliflozin may increase the excretion rate of Eszopiclone which could result in a lower serum level and potentially a reduction in efficacy.
Ganciclovir Ganciclovir Ertugliflozin may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.
Insulin Aspart (rDNA Origin) Injection Insulin Aspart (rDNA Origin) Injection The therapeutic efficacy of Insulin aspart can be increased when used in combination with Ertugliflozin.
Ribavirin Ribavirin Ertugliflozin may increase the excretion rate of Ribavirin which could result in a lower serum level and potentially a reduction in efficacy.
Valganciclovir Valganciclovir Ertugliflozin may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.
Dextroamphetamine Dextroamphetamine Ertugliflozin may increase the excretion rate of Amphetamine which could result in a lower serum level and potentially a reduction in efficacy.
Pramlintide Injection Pramlintide Injection The therapeutic efficacy of Pramlintide can be increased when used in combination with Ertugliflozin.
Exenatide Injection Exenatide Injection The therapeutic efficacy of Exenatide can be increased when used in combination with Ertugliflozin.
Isocarboxazid Isocarboxazid Isocarboxazid may increase the hypoglycemic activities of Ertugliflozin.
Ramelteon Ramelteon Ertugliflozin may increase the excretion rate of Ramelteon which could result in a lower serum level and potentially a reduction in efficacy.
Fentanyl Fentanyl Ertugliflozin may increase the excretion rate of Fentanyl which could result in a lower serum level and potentially a reduction in efficacy.
Pregabalin Pregabalin Ertugliflozin may increase the excretion rate of Pregabalin which could result in a lower serum level and potentially a reduction in efficacy.
Deferasirox Deferasirox The metabolism of Ertugliflozin can be decreased when combined with Deferasirox.
Tipranavir Tipranavir The serum concentration of Ertugliflozin can be increased when it is combined with Tipranavir.
Insulin Detemir (rDNA Origin) Injection Insulin Detemir (rDNA Origin) Injection The therapeutic efficacy of Insulin detemir can be increased when used in combination with Ertugliflozin.
Ranolazine Ranolazine The serum concentration of Ertugliflozin can be increased when it is combined with Ranolazine.
Rasagiline Rasagiline Ertugliflozin may increase the excretion rate of Rasagiline which could result in a lower serum level and potentially a reduction in efficacy.
Imatinib Imatinib Imatinib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Varenicline Varenicline Ertugliflozin may increase the excretion rate of Varenicline which could result in a lower serum level and potentially a reduction in efficacy.
Gefitinib Gefitinib Gefitinib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Albuterol Albuterol Ertugliflozin may increase the excretion rate of Salbutamol which could result in a lower serum level and potentially a reduction in efficacy.
Paliperidone Paliperidone The serum concentration of Ertugliflozin can be increased when it is combined with Paliperidone.
Bortezomib Bortezomib The serum concentration of Bortezomib can be increased when it is combined with Ertugliflozin.
Clofarabine Injection Clofarabine Injection Ertugliflozin may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.
Fulvestrant Injection Fulvestrant Injection The metabolism of Fulvestrant can be decreased when combined with Ertugliflozin.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection The therapeutic efficacy of Insulin glulisine can be increased when used in combination with Ertugliflozin.
Lubiprostone Lubiprostone The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Lubiprostone.
Posaconazole Posaconazole The serum concentration of Ertugliflozin can be increased when it is combined with Posaconazole.
Bismuth Subsalicylate Bismuth Subsalicylate Bismuth subsalicylate may increase the hypoglycemic activities of Ertugliflozin.
Darunavir Darunavir The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Darunavir.
Pemetrexed Injection Pemetrexed Injection Ertugliflozin may increase the excretion rate of Pemetrexed which could result in a lower serum level and potentially a reduction in efficacy.
Vorinostat Vorinostat The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Vorinostat.
Sorafenib Sorafenib The metabolism of Ertugliflozin can be decreased when combined with Sorafenib.
Sunitinib Sunitinib The therapeutic efficacy of Sunitinib can be increased when used in combination with Ertugliflozin.
Dronabinol Dronabinol Dronabinol may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Lapatinib Lapatinib The serum concentration of Ertugliflozin can be increased when it is combined with Lapatinib.
Levocetirizine Levocetirizine Ertugliflozin may increase the excretion rate of Levocetirizine which could result in a lower serum level and potentially a reduction in efficacy.
Pegaptanib Injection Pegaptanib Injection Ertugliflozin may increase the excretion rate of Pegaptanib which could result in a lower serum level and potentially a reduction in efficacy.
Dasatinib Dasatinib Dasatinib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Azacitidine Injection Azacitidine Injection Ertugliflozin may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy.
Paclitaxel (with polyoxyethylated castor oil) Injection Paclitaxel (with polyoxyethylated castor oil) Injection The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Castor oil.
Temsirolimus Temsirolimus The serum concentration of Ertugliflozin can be increased when it is combined with Temsirolimus.
Lenalidomide Lenalidomide Ertugliflozin may increase the excretion rate of Lenalidomide which could result in a lower serum level and potentially a reduction in efficacy.
Nilotinib Nilotinib The serum concentration of Ertugliflozin can be increased when it is combined with Nilotinib.
Toremifene Toremifene The serum concentration of Ertugliflozin can be increased when it is combined with Toremifene.
Raltegravir Raltegravir The metabolism of Raltegravir can be decreased when combined with Ertugliflozin.
Budesonide Budesonide The risk or severity of hyperglycemia can be increased when Ertugliflozin is combined with Budesonide.
Desmopressin Desmopressin Ertugliflozin may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
Doripenem Injection Doripenem Injection Ertugliflozin may increase the excretion rate of Doripenem which could result in a lower serum level and potentially a reduction in efficacy.
Arsenic Trioxide Injection Arsenic Trioxide Injection The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Arsenic trioxide.
Desvenlafaxine Desvenlafaxine Ertugliflozin may increase the excretion rate of Desvenlafaxine which could result in a lower serum level and potentially a reduction in efficacy.
Cevimeline Cevimeline Ertugliflozin may increase the excretion rate of Cevimeline which could result in a lower serum level and potentially a reduction in efficacy.
Nebivolol Nebivolol The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Nebivolol.
Bendamustine Injection Bendamustine Injection The serum concentration of Bendamustine can be increased when it is combined with Ertugliflozin.
Certolizumab Injection Certolizumab Injection Ertugliflozin may increase the excretion rate of Certolizumab pegol which could result in a lower serum level and potentially a reduction in efficacy.
Irinotecan Injection Irinotecan Injection The risk or severity of neutropenia can be increased when Ertugliflozin is combined with Irinotecan.
Daptomycin Injection Daptomycin Injection Ertugliflozin may increase the excretion rate of Daptomycin which could result in a lower serum level and potentially a reduction in efficacy.
Methylnaltrexone Injection Methylnaltrexone Injection Ertugliflozin may increase the excretion rate of Methylnaltrexone which could result in a lower serum level and potentially a reduction in efficacy.
Silodosin Silodosin The serum concentration of Ertugliflozin can be increased when it is combined with Silodosin.
Midazolam Midazolam Ertugliflozin may increase the excretion rate of Midazolam which could result in a lower serum level and potentially a reduction in efficacy.
Naltrexone Injection Naltrexone Injection The metabolism of Naltrexone can be decreased when combined with Ertugliflozin.
Dexrazoxane Injection Dexrazoxane Injection Ertugliflozin may increase the excretion rate of Dexrazoxane which could result in a lower serum level and potentially a reduction in efficacy.
Eltrombopag Eltrombopag The metabolism of Eltrombopag can be decreased when combined with Ertugliflozin.
Milnacipran Milnacipran Ertugliflozin may increase the excretion rate of Milnacipran which could result in a lower serum level and potentially a reduction in efficacy.
Plerixafor Injection Plerixafor Injection Ertugliflozin may increase the excretion rate of Plerixafor which could result in a lower serum level and potentially a reduction in efficacy.
Sodium Phosphate Sodium Phosphate Ertugliflozin may increase the nephrotoxic activities of Sodium phosphate, monobasic.
Fesoterodine Fesoterodine Ertugliflozin may increase the excretion rate of Fesoterodine which could result in a lower serum level and potentially a reduction in efficacy.
Betaxolol Betaxolol The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Betaxolol.
Iloperidone Iloperidone The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Iloperidone.
Prasugrel Prasugrel Ertugliflozin may increase the excretion rate of Prasugrel which could result in a lower serum level and potentially a reduction in efficacy.
Everolimus Everolimus The serum concentration of Ertugliflozin can be increased when it is combined with Everolimus.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) The serum concentration of Ertugliflozin can be increased when it is combined with Tolvaptan.
Dronedarone Dronedarone The serum concentration of Ertugliflozin can be increased when it is combined with Dronedarone.
Pralatrexate Injection Pralatrexate Injection Ertugliflozin may increase the excretion rate of Pralatrexate which could result in a lower serum level and potentially a reduction in efficacy.
Palonosetron Injection Palonosetron Injection Ertugliflozin may increase the excretion rate of Palonosetron which could result in a lower serum level and potentially a reduction in efficacy.
Saxagliptin Saxagliptin The therapeutic efficacy of Saxagliptin can be increased when used in combination with Ertugliflozin.
Telavancin Injection Telavancin Injection Ertugliflozin may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.
Romidepsin Injection Romidepsin Injection The serum concentration of Ertugliflozin can be increased when it is combined with Romidepsin.
Tapentadol Tapentadol The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Tapentadol.
Topotecan Topotecan Ertugliflozin may increase the excretion rate of Topotecan which could result in a lower serum level and potentially a reduction in efficacy.
Pazopanib Pazopanib The serum concentration of Ertugliflozin can be increased when it is combined with Pazopanib.
Asenapine Asenapine The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Asenapine.
Levonorgestrel Levonorgestrel The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Levonorgestrel.
Oxymorphone Oxymorphone The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Oxymorphone.
Liraglutide Injection Liraglutide Injection The therapeutic efficacy of Liraglutide can be increased when used in combination with Ertugliflozin.
Dalfampridine Dalfampridine Ertugliflozin may increase the excretion rate of Dalfampridine which could result in a lower serum level and potentially a reduction in efficacy.
Cabazitaxel Injection Cabazitaxel Injection Cabazitaxel may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Lurasidone Lurasidone The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Lurasidone.
Acetaminophen Injection Acetaminophen Injection The metabolism of Acetaminophen can be decreased when combined with Ertugliflozin.
Ipilimumab Injection Ipilimumab Injection Ertugliflozin may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.
Denileukin Diftitox Injection Denileukin Diftitox Injection Ertugliflozin may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.
Terbutaline Injection Terbutaline Injection Ertugliflozin may increase the excretion rate of Terbutaline which could result in a lower serum level and potentially a reduction in efficacy.
Roflumilast Roflumilast Ertugliflozin may increase the excretion rate of Roflumilast which could result in a lower serum level and potentially a reduction in efficacy.
Linagliptin Linagliptin The therapeutic efficacy of Linagliptin can be increased when used in combination with Ertugliflozin.
Rilpivirine Rilpivirine Rilpivirine may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Telaprevir Telaprevir The serum concentration of Ertugliflozin can be increased when it is combined with Glecaprevir.
Triptorelin Injection Triptorelin Injection The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Triptorelin.
Rivaroxaban Rivaroxaban The serum concentration of Ertugliflozin can be increased when it is combined with Rivaroxaban.
Ticagrelor Ticagrelor The serum concentration of Ertugliflozin can be increased when it is combined with Ticagrelor.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The serum concentration of Brentuximab vedotin can be increased when it is combined with Ertugliflozin.
Ruxolitinib Ruxolitinib Ertugliflozin may increase the excretion rate of Ruxolitinib which could result in a lower serum level and potentially a reduction in efficacy.
Vandetanib Vandetanib Vandetanib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Clobazam Clobazam The serum concentration of Ertugliflozin can be increased when it is combined with Clobazam.
Vemurafenib Vemurafenib The serum concentration of Ertugliflozin can be increased when it is combined with Vemurafenib.
Vismodegib Vismodegib Vismodegib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Ivacaftor Ivacaftor The serum concentration of Ertugliflozin can be increased when it is combined with Ivacaftor.
Deferiprone Deferiprone Ertugliflozin may increase the excretion rate of Deferiprone which could result in a lower serum level and potentially a reduction in efficacy.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Ertugliflozin.
Crizotinib Crizotinib The serum concentration of Ertugliflozin can be increased when it is combined with Crizotinib.
Cabergoline Cabergoline The serum concentration of Cabergoline can be increased when it is combined with Ertugliflozin.
Naloxone Injection Naloxone Injection The metabolism of Naloxone can be decreased when combined with Ertugliflozin.
Ambrisentan Ambrisentan The serum concentration of Ertugliflozin can be increased when it is combined with Ambrisentan.
Fondaparinux Injection Fondaparinux Injection Ertugliflozin may increase the excretion rate of Fondaparinux which could result in a lower serum level and potentially a reduction in efficacy.
Ezogabine Ezogabine The metabolism of Tiagabine can be decreased when combined with Ertugliflozin.
Carfilzomib Injection Carfilzomib Injection The serum concentration of Ertugliflozin can be increased when it is combined with Carfilzomib.
Enzalutamide Enzalutamide The serum concentration of Ertugliflozin can be increased when it is combined with Enzalutamide.
Mirabegron Mirabegron The serum concentration of Ertugliflozin can be increased when it is combined with Mirabegron.
Regorafenib Regorafenib The metabolism of Ertugliflozin can be decreased when combined with Regorafenib.
Bosutinib Bosutinib The serum concentration of Bosutinib can be increased when it is combined with Ertugliflozin.
Corticotropin, Repository Injection Corticotropin, Repository Injection The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Ertugliflozin.
Linaclotide Linaclotide The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Linaclotide.
Teriflunomide Teriflunomide Teriflunomide may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Lorcaserin Lorcaserin The therapeutic efficacy of Mecasermin can be increased when used in combination with Ertugliflozin.
Teduglutide Injection Teduglutide Injection Ertugliflozin may increase the excretion rate of Teduglutide which could result in a lower serum level and potentially a reduction in efficacy.
Alogliptin Alogliptin The therapeutic efficacy of Alogliptin can be increased when used in combination with Ertugliflozin.
Ponatinib Ponatinib The serum concentration of Ertugliflozin can be increased when it is combined with Ponatinib.
Pomalidomide Pomalidomide The serum concentration of Ertugliflozin can be increased when it is combined with Pomalidomide.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The serum concentration of Ertugliflozin can be increased when it is combined with Trastuzumab emtansine.
Apixaban Apixaban The serum concentration of Ertugliflozin can be increased when it is combined with Apixaban.
Canagliflozin Canagliflozin The therapeutic efficacy of Canagliflozin can be increased when used in combination with Ertugliflozin.
Methazolamide Methazolamide The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Methazolamide.
Dabrafenib Dabrafenib Dabrafenib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Trametinib Trametinib Ertugliflozin may increase the excretion rate of Trametinib which could result in a lower serum level and potentially a reduction in efficacy.
Dolutegravir Dolutegravir The metabolism of Dolutegravir can be decreased when combined with Ertugliflozin.
Afatinib Afatinib The serum concentration of Ertugliflozin can be increased when it is combined with Afatinib.
Levomilnacipran Levomilnacipran The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Ertugliflozin.
Ertapenem Injection Ertapenem Injection Ertugliflozin may increase the excretion rate of Ertapenem which could result in a lower serum level and potentially a reduction in efficacy.
Vortioxetine Vortioxetine Ertugliflozin may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy.
Lomitapide Lomitapide The serum concentration of Ertugliflozin can be increased when it is combined with Lomitapide.
Simeprevir Simeprevir The serum concentration of Ertugliflozin can be increased when it is combined with Simeprevir.
Sofosbuvir Sofosbuvir The serum concentration of Ertugliflozin can be increased when it is combined with Sofosbuvir.
Dapagliflozin Dapagliflozin The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Ertugliflozin.
Apremilast Apremilast Ertugliflozin may increase the excretion rate of Apremilast which could result in a lower serum level and potentially a reduction in efficacy.
Droxidopa Droxidopa The risk or severity of Cardiac Arrhythmia can be increased when Droxidopa is combined with Ertugliflozin.
Ceritinib Ceritinib The serum concentration of Ertugliflozin can be increased when it is combined with Ceritinib.
Albiglutide Injection Albiglutide Injection The therapeutic efficacy of Albiglutide can be increased when used in combination with Ertugliflozin.
Eslicarbazepine Eslicarbazepine The metabolism of Eslicarbazepine can be decreased when combined with Ertugliflozin.
Belinostat Injection Belinostat Injection The metabolism of Belinostat can be decreased when combined with Ertugliflozin.
Idelalisib Idelalisib The serum concentration of Ertugliflozin can be increased when it is combined with Idelalisib.
Testosterone Injection Testosterone Injection Testosterone may increase the excretion rate of Ertugliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Empagliflozin Empagliflozin The therapeutic efficacy of Empagliflozin can be increased when used in combination with Ertugliflozin.
Vorapaxar Vorapaxar The serum concentration of Ertugliflozin can be increased when it is combined with Vorapaxar.
Hydrocodone Hydrocodone The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Hydrocodone.
Suvorexant Suvorexant The serum concentration of Ertugliflozin can be increased when it is combined with Suvorexant.
Dulaglutide Injection Dulaglutide Injection The therapeutic efficacy of Dulaglutide can be increased when used in combination with Ertugliflozin.
Edoxaban Edoxaban The serum concentration of Ertugliflozin can be increased when it is combined with Edoxaban.
Olaparib Olaparib Olaparib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Methamphetamine Methamphetamine Ertugliflozin may increase the excretion rate of Metamfetamine which could result in a lower serum level and potentially a reduction in efficacy.
Tasimelteon Tasimelteon Ertugliflozin may increase the excretion rate of Tasimelteon which could result in a lower serum level and potentially a reduction in efficacy.
Lanreotide Injection Lanreotide Injection The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Lanreotide.
Nintedanib Nintedanib The serum concentration of Ertugliflozin can be increased when it is combined with Nintedanib.
Risperidone Injection Risperidone Injection The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Risperidone.
Palbociclib Palbociclib Palbociclib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Insulin Human Inhalation Insulin Human Inhalation The therapeutic efficacy of Insulin human can be increased when used in combination with Ertugliflozin.
Lenvatinib Lenvatinib The serum concentration of Ertugliflozin can be increased when it is combined with Lenvatinib.
Panobinostat Panobinostat The serum concentration of Ertugliflozin can be increased when it is combined with Panobinostat.
Haloperidol Injection Haloperidol Injection The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Haloperidol.
Isavuconazonium Injection Isavuconazonium Injection The serum concentration of Ertugliflozin can be increased when it is combined with Isavuconazonium.
Macitentan Macitentan Ertugliflozin may increase the excretion rate of Macitentan which could result in a lower serum level and potentially a reduction in efficacy.
Flibanserin Flibanserin The serum concentration of Ertugliflozin can be increased when it is combined with Flibanserin.
Rolapitant Rolapitant The serum concentration of Ertugliflozin can be increased when it is combined with Rolapitant.
Prednisolone Prednisolone The risk or severity of hyperglycemia can be increased when Prednisolone is combined with Ertugliflozin.
Daclatasvir Daclatasvir The serum concentration of Ertugliflozin can be increased when it is combined with Daclatasvir.
Brexpiprazole Brexpiprazole The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Brexpiprazole.
Ziprasidone Injection Ziprasidone Injection The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Ziprasidone.
Penicillin G Procaine Injection Penicillin G Procaine Injection Ertugliflozin may increase the excretion rate of Procaine benzylpenicillin which could result in a lower serum level and potentially a reduction in efficacy.
Eluxadoline Eluxadoline The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Eluxadoline.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection The therapeutic efficacy of Insulin degludec can be increased when used in combination with Ertugliflozin.
Cobimetinib Cobimetinib The serum concentration of Ertugliflozin can be increased when it is combined with Cobimetinib.
Osimertinib Osimertinib The serum concentration of Ertugliflozin can be increased when it is combined with Osimertinib.
Alectinib Alectinib Alectinib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Ixazomib Ixazomib Ertugliflozin may increase the excretion rate of Ixazomib which could result in a lower serum level and potentially a reduction in efficacy.
Lesinurad Lesinurad Ertugliflozin may increase the excretion rate of Lesinurad which could result in a lower serum level and potentially a reduction in efficacy.
Dexamethasone Injection Dexamethasone Injection The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Ertugliflozin.
Brivaracetam Injection Brivaracetam Injection Ertugliflozin may increase the excretion rate of Brivaracetam which could result in a lower serum level and potentially a reduction in efficacy.
Venetoclax Venetoclax The serum concentration of Ertugliflozin can be increased when it is combined with Venetoclax.
Cobicistat Cobicistat The serum concentration of Ertugliflozin can be increased when it is combined with Cobicistat.
Selexipag Selexipag The serum concentration of Ertugliflozin can be increased when it is combined with Selexipag.
Furosemide Injection Furosemide Injection The metabolism of Furosemide can be decreased when combined with Ertugliflozin.
Rucaparib Rucaparib The serum concentration of Ertugliflozin can be increased when it is combined with Rucaparib.
Lixisenatide Injection Lixisenatide Injection The therapeutic efficacy of Lixisenatide can be increased when used in combination with Ertugliflozin.
Brigatinib Brigatinib Brigatinib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Doxepin (Insomnia) Doxepin (Insomnia) Doxepin may decrease the hypoglycemic activities of Ertugliflozin.
Plecanatide Plecanatide The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Plecanatide.
Deutetrabenazine Deutetrabenazine Ertugliflozin may increase the excretion rate of Deutetrabenazine which could result in a lower serum level and potentially a reduction in efficacy.
Valbenazine Valbenazine Ertugliflozin may increase the excretion rate of Valbenazine which could result in a lower serum level and potentially a reduction in efficacy.
Deflazacort Deflazacort The risk or severity of hyperglycemia can be increased when Deflazacort is combined with Ertugliflozin.
Safinamide Safinamide Safinamide may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Naldemedine Naldemedine Ertugliflozin may increase the excretion rate of Naldemedine which could result in a lower serum level and potentially a reduction in efficacy.
Neratinib Neratinib The serum concentration of Ertugliflozin can be increased when it is combined with Neratinib.
Enasidenib Enasidenib The metabolism of Enasidenib can be decreased when combined with Ertugliflozin.
Inotuzumab Ozogamicin Injection Inotuzumab Ozogamicin Injection The serum concentration of Ertugliflozin can be increased when it is combined with Inotuzumab ozogamicin.
Benznidazole Benznidazole Ertugliflozin may increase the excretion rate of Benznidazole which could result in a lower serum level and potentially a reduction in efficacy.
Copanlisib Injection Copanlisib Injection The serum concentration of Copanlisib can be increased when it is combined with Ertugliflozin.
Delafloxacin Delafloxacin The metabolism of Delafloxacin can be decreased when combined with Ertugliflozin.
Abemaciclib Abemaciclib Abemaciclib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Betrixaban Betrixaban The serum concentration of Betrixaban can be increased when it is combined with Ertugliflozin.
Letermovir Letermovir The metabolism of Letermovir can be decreased when combined with Ertugliflozin.
Semaglutide Injection Semaglutide Injection The therapeutic efficacy of Semaglutide can be increased when used in combination with Ertugliflozin.
Buprenorphine Injection Buprenorphine Injection The metabolism of Buprenorphine can be decreased when combined with Ertugliflozin.
Apalutamide Apalutamide The serum concentration of Ertugliflozin can be decreased when it is combined with Apalutamide.
Fostamatinib Fostamatinib Fostamatinib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Avatrombopag Avatrombopag Avatrombopag may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Baricitinib Baricitinib Baricitinib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Lofexidine Lofexidine Ertugliflozin may increase the excretion rate of Lofexidine which could result in a lower serum level and potentially a reduction in efficacy.
Plazomicin Injection Plazomicin Injection Ertugliflozin may increase the excretion rate of Plazomicin which could result in a lower serum level and potentially a reduction in efficacy.
Eliglustat Eliglustat The serum concentration of Ertugliflozin can be increased when it is combined with Eliglustat.
Binimetinib Binimetinib The metabolism of Binimetinib can be decreased when combined with Ertugliflozin.
Ivosidenib Ivosidenib The serum concentration of Ertugliflozin can be increased when it is combined with Ivosidenib.
Lusutrombopag Lusutrombopag The serum concentration of Lusutrombopag can be increased when it is combined with Ertugliflozin.
Elagolix Elagolix The metabolism of Elagolix can be decreased when combined with Ertugliflozin.
Cannabidiol Cannabidiol Cannabidiol may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Dacomitinib Dacomitinib Dacomitinib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Duvelisib Duvelisib The serum concentration of Duvelisib can be increased when it is combined with Ertugliflozin.
Omadacycline Omadacycline The serum concentration of Omadacycline can be increased when it is combined with Ertugliflozin.
Sarecycline Sarecycline The serum concentration of Ertugliflozin can be increased when it is combined with Sarecycline.
Stiripentol Stiripentol Ertugliflozin may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy.
Talazoparib Talazoparib The serum concentration of Ertugliflozin can be increased when it is combined with Talazoparib.
Gilteritinib Gilteritinib Gilteritinib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Glasdegib Glasdegib Glasdegib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Larotrectinib Larotrectinib The serum concentration of Larotrectinib can be increased when it is combined with Ertugliflozin.
Rifamycin Rifamycin The serum concentration of Ertugliflozin can be increased when it is combined with Rifamycin.
Prucalopride Prucalopride The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Prucalopride.
Magnesium Citrate Magnesium Citrate The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Magnesium citrate.
Acyclovir Ophthalmic Acyclovir Ophthalmic Ertugliflozin may increase the excretion rate of Acyclovir which could result in a lower serum level and potentially a reduction in efficacy.
Erdafitinib Erdafitinib The serum concentration of Ertugliflozin can be increased when it is combined with Erdafitinib.
Solriamfetol Solriamfetol Ertugliflozin may increase the excretion rate of Solriamfetol which could result in a lower serum level and potentially a reduction in efficacy.
Darolutamide Darolutamide The serum concentration of Ertugliflozin can be increased when it is combined with Darolutamide.
Entrectinib Entrectinib The serum concentration of Ertugliflozin can be increased when it is combined with Entrectinib.
Istradefylline Istradefylline Istradefylline may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Pitolisant Pitolisant The serum concentration of Ertugliflozin can be increased when it is combined with Pitolisant.
Fedratinib Fedratinib Fedratinib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Lefamulin Lefamulin The serum concentration of Lefamulin can be increased when it is combined with Ertugliflozin.
Phenytoin Injection Phenytoin Injection The metabolism of Ertugliflozin can be decreased when combined with Phenytoin.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Ertugliflozin can be decreased when combined with Fosphenytoin.
Enfortumab vedotin-ejfv Injection Enfortumab vedotin-ejfv Injection The serum concentration of Enfortumab vedotin can be increased when it is combined with Ertugliflozin.
Lumateperone Lumateperone The serum concentration of Lumateperone can be increased when it is combined with Ertugliflozin.
Lasmiditan Lasmiditan The serum concentration of Ertugliflozin can be increased when it is combined with Lasmiditan.
Ubrogepant Ubrogepant The serum concentration of Ubrogepant can be increased when it is combined with Ertugliflozin.
Tazemetostat Tazemetostat The serum concentration of Tazemetostat can be increased when it is combined with Ertugliflozin.
Teprotumumab-trbw Injection Teprotumumab-trbw Injection The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Teprotumumab.
Selumetinib Selumetinib The metabolism of Selumetinib can be decreased when combined with Ertugliflozin.
Rimegepant Rimegepant The serum concentration of Rimegepant can be increased when it is combined with Ertugliflozin.
Tucatinib Tucatinib Tucatinib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Remdesivir Injection Remdesivir Injection The serum concentration of Remdesivir can be increased when it is combined with Ertugliflozin.
Sacituzumab govitecan-hziy Injection Sacituzumab govitecan-hziy Injection The serum concentration of Sacituzumab govitecan can be increased when it is combined with Ertugliflozin.
Ripretinib Ripretinib Ripretinib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Capmatinib Capmatinib The serum concentration of Ertugliflozin can be increased when it is combined with Capmatinib.
Lemborexant Lemborexant The serum concentration of Lemborexant can be increased when it is combined with Ertugliflozin.
Fostemsavir Fostemsavir Fostemsavir may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Octreotide Octreotide The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Octreotide.
Belantamab Mafodotin-blmf Injection Belantamab Mafodotin-blmf Injection The serum concentration of Belantamab mafodotin can be increased when it is combined with Ertugliflozin.
Pralsetinib Pralsetinib Pralsetinib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Drospirenone.
Viloxazine Viloxazine Ertugliflozin may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.
Indomethacin Indomethacin The metabolism of Ertugliflozin can be decreased when combined with Indomethacin.
Mefenamic Acid Mefenamic Acid The metabolism of Ertugliflozin can be decreased when combined with Mefenamic acid.
Naproxen Naproxen The metabolism of Naproxen can be decreased when combined with Ertugliflozin.
Isotretinoin Isotretinoin Ertugliflozin may increase the excretion rate of Isotretinoin which could result in a lower serum level and potentially a reduction in efficacy.
Sucralfate Sucralfate Ertugliflozin may increase the excretion rate of Sucralfate which could result in a lower serum level and potentially a reduction in efficacy.
Floxuridine Floxuridine Ertugliflozin may increase the excretion rate of Floxuridine which could result in a lower serum level and potentially a reduction in efficacy.
Phenobarbital Phenobarbital The metabolism of Ertugliflozin can be increased when combined with Phenobarbital.
Metaxalone Metaxalone Ertugliflozin may increase the excretion rate of Metaxalone which could result in a lower serum level and potentially a reduction in efficacy.
Methotrexate Injection Methotrexate Injection Ertugliflozin may increase the excretion rate of Methotrexate which could result in a lower serum level and potentially a reduction in efficacy.
Levorphanol Levorphanol The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Levorphanol.
Methsuximide Methsuximide The risk or severity of hypoglycemia can be increased when Methsuximide is combined with Ertugliflozin.
Chlorpromazine Chlorpromazine The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Chlorpromazine.
Diazepam Diazepam Ertugliflozin may increase the excretion rate of Diazepam which could result in a lower serum level and potentially a reduction in efficacy.
Oxazepam Oxazepam Ertugliflozin may increase the excretion rate of Oxazepam which could result in a lower serum level and potentially a reduction in efficacy.
Flurazepam Flurazepam Ertugliflozin may increase the excretion rate of Flurazepam which could result in a lower serum level and potentially a reduction in efficacy.
Clorazepate Clorazepate Ertugliflozin may increase the excretion rate of Clorazepic acid which could result in a lower serum level and potentially a reduction in efficacy.
Lorazepam Lorazepam Ertugliflozin may increase the excretion rate of Lorazepam which could result in a lower serum level and potentially a reduction in efficacy.
Carmustine Carmustine Ertugliflozin may increase the excretion rate of Carmustine which could result in a lower serum level and potentially a reduction in efficacy.
Amantadine Amantadine Ertugliflozin may increase the excretion rate of Amantadine which could result in a lower serum level and potentially a reduction in efficacy.
Codeine Codeine The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Codeine.
Bromocriptine Bromocriptine The therapeutic efficacy of Bromocriptine can be increased when used in combination with Ertugliflozin.
Tranylcypromine Tranylcypromine Tranylcypromine may increase the hypoglycemic activities of Ertugliflozin.
Phenelzine Phenelzine Ertugliflozin may increase the excretion rate of Phenelzine which could result in a lower serum level and potentially a reduction in efficacy.
Procarbazine Procarbazine Procarbazine may increase the hypoglycemic activities of Ertugliflozin.
Tetracycline Tetracycline Ertugliflozin may increase the excretion rate of Tetracycline which could result in a lower serum level and potentially a reduction in efficacy.
Bleomycin Bleomycin Ertugliflozin may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy.
Sulfadiazine Sulfadiazine The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Ertugliflozin.
Oxycodone Oxycodone The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Oxycodone.
Methadone Methadone Ertugliflozin may increase the excretion rate of Methadone which could result in a lower serum level and potentially a reduction in efficacy.
Benztropine Benztropine Ertugliflozin may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
Maprotiline Maprotiline Ertugliflozin may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy.
Ibuprofen Ibuprofen The metabolism of Ibuprofen can be decreased when combined with Ertugliflozin.
Azathioprine Azathioprine Ertugliflozin may increase the excretion rate of Azathioprine which could result in a lower serum level and potentially a reduction in efficacy.
Phentermine Phentermine The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Phentermine.
Methylphenidate Methylphenidate Ertugliflozin may increase the excretion rate of Methylphenidate which could result in a lower serum level and potentially a reduction in efficacy.
Amoxapine Amoxapine Amoxapine may decrease the hypoglycemic activities of Ertugliflozin.
Sulfasalazine Sulfasalazine Sulfasalazine may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Hydrocortisone Hydrocortisone The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Ertugliflozin.
Dactinomycin Dactinomycin The serum concentration of Ertugliflozin can be increased when it is combined with Dactinomycin.
Phenazopyridine Phenazopyridine Ertugliflozin may increase the excretion rate of Phenazopyridine which could result in a lower serum level and potentially a reduction in efficacy.
Carbamazepine Carbamazepine Ertugliflozin may increase the excretion rate of Carbamazepine which could result in a lower serum level and potentially a reduction in efficacy.
Methyldopa Methyldopa Ertugliflozin may increase the excretion rate of Methyldopa which could result in a lower serum level and potentially a reduction in efficacy.
Hydralazine Hydralazine Ertugliflozin may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.
Cimetidine Cimetidine Ertugliflozin may increase the excretion rate of Cimetidine which could result in a lower serum level and potentially a reduction in efficacy.
Warfarin Warfarin Ertugliflozin may increase the excretion rate of Warfarin which could result in a lower serum level and potentially a reduction in efficacy.
Clonazepam Clonazepam Ertugliflozin may increase the excretion rate of Clonazepam which could result in a lower serum level and potentially a reduction in efficacy.
Loperamide Loperamide The serum concentration of Ertugliflozin can be increased when it is combined with Loperamide.
Promethazine Promethazine Ertugliflozin may increase the excretion rate of Promethazine which could result in a lower serum level and potentially a reduction in efficacy.
Meclofenamate Meclofenamate Ertugliflozin may increase the excretion rate of Meclofenamic acid which could result in a lower serum level and potentially a reduction in efficacy.
Nitrofurantoin Nitrofurantoin Ertugliflozin may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.
Digoxin Digoxin The serum concentration of Digoxin can be increased when it is combined with Ertugliflozin.
Loxapine Loxapine The serum concentration of Ertugliflozin can be increased when it is combined with Loxapine.
Chloroquine Chloroquine Ertugliflozin may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.
Quinine Quinine The therapeutic efficacy of Quinine can be increased when used in combination with Ertugliflozin.
Ethosuximide Ethosuximide The risk or severity of hypoglycemia can be increased when Ethosuximide is combined with Ertugliflozin.
Lactulose Lactulose The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Lactulose.
Chlorothiazide Chlorothiazide The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Chlorothiazide.
Chlorthalidone Chlorthalidone The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Chlorthalidone.
Metolazone Metolazone The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Metolazone.
Secobarbital Secobarbital Ertugliflozin may increase the excretion rate of Secobarbital which could result in a lower serum level and potentially a reduction in efficacy.
Desipramine Desipramine Desipramine may decrease the hypoglycemic activities of Ertugliflozin.
Amitriptyline Amitriptyline Amitriptyline may decrease the hypoglycemic activities of Ertugliflozin.
Imipramine Imipramine Imipramine may decrease the hypoglycemic activities of Ertugliflozin.
Probenecid Probenecid The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Probenecid.
Quinidine Quinidine The serum concentration of Ertugliflozin can be increased when it is combined with Quinidine.
Procainamide Procainamide Ertugliflozin may increase the excretion rate of Procainamide which could result in a lower serum level and potentially a reduction in efficacy.
Isoniazid Isoniazid Ertugliflozin may increase the excretion rate of Isoniazid which could result in a lower serum level and potentially a reduction in efficacy.
Pyrazinamide Pyrazinamide Ertugliflozin may increase the excretion rate of Pyrazinamide which could result in a lower serum level and potentially a reduction in efficacy.
Rifampin Rifampin The metabolism of Ertugliflozin can be increased when combined with Rifampicin.
Disopyramide Disopyramide The therapeutic efficacy of Disopyramide can be increased when used in combination with Ertugliflozin.
Valproic Acid Valproic Acid The metabolism of Valproic acid can be decreased when combined with Ertugliflozin.
Tamoxifen Tamoxifen The serum concentration of Ertugliflozin can be increased when it is combined with Tamoxifen.
Butabarbital Butabarbital Ertugliflozin may increase the excretion rate of Butabarbital which could result in a lower serum level and potentially a reduction in efficacy.
Levothyroxine Levothyroxine The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Ertugliflozin.
Liothyronine Liothyronine The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Liothyronine.
Methimazole Methimazole Ertugliflozin may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.
Chlorpropamide Chlorpropamide The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Ertugliflozin.
Tolbutamide Tolbutamide The therapeutic efficacy of Tolbutamide can be increased when used in combination with Ertugliflozin.
Tolazamide Tolazamide The therapeutic efficacy of Tolazamide can be increased when used in combination with Ertugliflozin.
Niacin Niacin The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Niacin.
Baclofen Baclofen The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Baclofen.
Ethambutol Ethambutol Ertugliflozin may increase the excretion rate of Ethambutol which could result in a lower serum level and potentially a reduction in efficacy.
Methyclothiazide Methyclothiazide The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Methyclothiazide.
Hydrochlorothiazide Hydrochlorothiazide The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Hydrochlorothiazide.
Chlorzoxazone Chlorzoxazone Ertugliflozin may increase the excretion rate of Chlorzoxazone which could result in a lower serum level and potentially a reduction in efficacy.
Pyridoxine Pyridoxine Ertugliflozin may increase the excretion rate of Pyridoxine which could result in a lower serum level and potentially a reduction in efficacy.
Folic Acid Folic Acid Ertugliflozin may increase the excretion rate of Folic acid which could result in a lower serum level and potentially a reduction in efficacy.
Danazol Danazol The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Danazol.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Propranolol.
Minoxidil Minoxidil The metabolism of Minoxidil can be decreased when combined with Ertugliflozin.
Pseudoephedrine Pseudoephedrine The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Pseudoephedrine.
Nortriptyline Nortriptyline Nortriptyline may decrease the hypoglycemic activities of Ertugliflozin.
Phytonadione Phytonadione Ertugliflozin may increase the excretion rate of Phylloquinone which could result in a lower serum level and potentially a reduction in efficacy.
Nadolol Nadolol The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Nadolol.
Butorphanol Injection Butorphanol Injection The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Butorphanol.
Nalbuphine Injection Nalbuphine Injection The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Nalbuphine.
Allopurinol Allopurinol Ertugliflozin may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy.
Fluoxymesterone Fluoxymesterone Fluoxymesterone may increase the hypoglycemic activities of Ertugliflozin.
Clomiphene Clomiphene The serum concentration of Ertugliflozin can be increased when it is combined with Clomifene.
Flavoxate Flavoxate Ertugliflozin may increase the excretion rate of Flavoxate which could result in a lower serum level and potentially a reduction in efficacy.
Colchicine Colchicine The serum concentration of Ertugliflozin can be increased when it is combined with Colchicine.
Cefaclor Cefaclor Ertugliflozin may increase the excretion rate of Cefaclor which could result in a lower serum level and potentially a reduction in efficacy.
Cefadroxil Cefadroxil Ertugliflozin may increase the excretion rate of Cefadroxil which could result in a lower serum level and potentially a reduction in efficacy.
Cephalexin Cephalexin Ertugliflozin may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.
Dacarbazine Dacarbazine Ertugliflozin may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.
Acetazolamide Acetazolamide The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Acetazolamide.
Calcitonin Salmon Injection Calcitonin Salmon Injection Ertugliflozin may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
Ketoconazole Ketoconazole The serum concentration of Ertugliflozin can be increased when it is combined with Ketoconazole.
Pyrantel Pyrantel Ertugliflozin may increase the excretion rate of Pyrantel which could result in a lower serum level and potentially a reduction in efficacy.
Vincristine Injection Vincristine Injection The serum concentration of Vincristine can be increased when it is combined with Ertugliflozin.
Captopril Captopril The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Captopril is combined with Ertugliflozin.
Vinblastine Vinblastine The serum concentration of Ertugliflozin can be increased when it is combined with Vinblastine.
Ethacrynic Acid Ethacrynic Acid The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Etacrynic acid.
Metoprolol Metoprolol The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Metoprolol.
Aspirin Aspirin Acetylsalicylic acid may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Alprazolam Alprazolam Ertugliflozin may increase the excretion rate of Alprazolam which could result in a lower serum level and potentially a reduction in efficacy.
Temazepam Temazepam Ertugliflozin may increase the excretion rate of Temazepam which could result in a lower serum level and potentially a reduction in efficacy.
Triazolam Triazolam Ertugliflozin may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Dicyclomine Dicyclomine Ertugliflozin may increase the excretion rate of Dicyclomine which could result in a lower serum level and potentially a reduction in efficacy.
Propantheline Propantheline Ertugliflozin may increase the excretion rate of Propantheline which could result in a lower serum level and potentially a reduction in efficacy.
Trimethoprim Trimethoprim Ertugliflozin may increase the excretion rate of Trimethoprim which could result in a lower serum level and potentially a reduction in efficacy.
Diltiazem Diltiazem The risk or severity of hypoglycemia can be increased when Diltiazem is combined with Ertugliflozin.
Nifedipine Nifedipine Nifedipine may increase the excretion rate of Ertugliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Timolol Timolol The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Timolol.
Verapamil Verapamil The serum concentration of Ertugliflozin can be increased when it is combined with Verapamil.
Atenolol Atenolol The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Atenolol.
Pindolol Pindolol The therapeutic efficacy of Pindolol can be increased when used in combination with Ertugliflozin.
Cisplatin Injection Cisplatin Injection Ertugliflozin may increase the excretion rate of Cisplatin which could result in a lower serum level and potentially a reduction in efficacy.
Diflunisal Diflunisal The metabolism of Ertugliflozin can be decreased when combined with Diflunisal.
Piroxicam Piroxicam Ertugliflozin may increase the excretion rate of Piroxicam which could result in a lower serum level and potentially a reduction in efficacy.
Bumetanide Bumetanide The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Bumetanide.
Etoposide Etoposide The metabolism of Etoposide can be decreased when combined with Ertugliflozin.
Glyburide Glyburide The therapeutic efficacy of Glyburide can be increased when used in combination with Ertugliflozin.
Glipizide Glipizide The therapeutic efficacy of Glipizide can be increased when used in combination with Ertugliflozin.
Indapamide Indapamide The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Indapamide.
Amoxicillin Amoxicillin Ertugliflozin may increase the excretion rate of Amoxicillin which could result in a lower serum level and potentially a reduction in efficacy.
Oxacillin Injection Oxacillin Injection Ertugliflozin may increase the excretion rate of Oxacillin which could result in a lower serum level and potentially a reduction in efficacy.
Pentoxifylline Pentoxifylline Ertugliflozin may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.
Pentamidine Injection Pentamidine Injection The therapeutic efficacy of Pentamidine can be increased when used in combination with Ertugliflozin.
Ceftriaxone Injection Ceftriaxone Injection Ertugliflozin may increase the excretion rate of Ceftriaxone which could result in a lower serum level and potentially a reduction in efficacy.
Labetalol Labetalol The therapeutic efficacy of Labetalol can be increased when used in combination with Ertugliflozin.
Auranofin Auranofin Ertugliflozin may increase the excretion rate of Auranofin which could result in a lower serum level and potentially a reduction in efficacy.
Leuprolide Injection Leuprolide Injection The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Leuprolide.
Gemfibrozil Gemfibrozil The metabolism of Gemfibrozil can be decreased when combined with Ertugliflozin.
Ceftazidime Injection Ceftazidime Injection Ertugliflozin may increase the excretion rate of Ceftazidime which could result in a lower serum level and potentially a reduction in efficacy.
Ketoprofen Ketoprofen The metabolism of Ketoprofen can be decreased when combined with Ertugliflozin.
Cefotetan Injection Cefotetan Injection Ertugliflozin may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.
Enalapril Enalapril The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Enalapril is combined with Ertugliflozin.
Flurbiprofen Flurbiprofen The metabolism of Flurbiprofen can be decreased when combined with Ertugliflozin.
Amiodarone Amiodarone The serum concentration of Ertugliflozin can be increased when it is combined with Amiodarone.
Aztreonam Injection Aztreonam Injection Ertugliflozin may increase the excretion rate of Aztreonam which could result in a lower serum level and potentially a reduction in efficacy.
Buspirone Buspirone Ertugliflozin may increase the excretion rate of Buspirone which could result in a lower serum level and potentially a reduction in efficacy.
Lovastatin Lovastatin The metabolism of Lovastatin can be decreased when combined with Ertugliflozin.
Ciprofloxacin Ciprofloxacin The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Ciprofloxacin.
Mesalamine Mesalamine Mesalazine may increase the hypoglycemic activities of Ertugliflozin.
Diclofenac Diclofenac The metabolism of Diclofenac can be decreased when combined with Ertugliflozin.
Fluoxetine Fluoxetine The risk or severity of hypoglycemia can be increased when Fluoxetine is combined with Ertugliflozin.
Nimodipine Nimodipine The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Ertugliflozin.
Clozapine Clozapine The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Clozapine.
Estazolam Estazolam Ertugliflozin may increase the excretion rate of Estazolam which could result in a lower serum level and potentially a reduction in efficacy.
Ofloxacin Ofloxacin The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Ofloxacin.
Didanosine Didanosine Ertugliflozin may increase the excretion rate of Didanosine which could result in a lower serum level and potentially a reduction in efficacy.
Pentostatin Injection Pentostatin Injection Ertugliflozin may increase the excretion rate of Pentostatin which could result in a lower serum level and potentially a reduction in efficacy.
Clarithromycin Clarithromycin The serum concentration of Ertugliflozin can be increased when it is combined with Clarithromycin.
Benazepril Benazepril The risk or severity of hypoglycemia can be increased when Benazepril is combined with Ertugliflozin.
Etodolac Etodolac Ertugliflozin may increase the excretion rate of Etodolac which could result in a lower serum level and potentially a reduction in efficacy.
Felodipine Felodipine The risk or severity of hypoglycemia can be increased when Felodipine is combined with Ertugliflozin.
Fosinopril Fosinopril The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Ertugliflozin is combined with Fosinopril.
Pravastatin Pravastatin Pravastatin may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Quinapril Quinapril The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Ertugliflozin is combined with Quinapril.
Ramipril Ramipril The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Ertugliflozin is combined with Ramipril.
Simvastatin Simvastatin The metabolism of Simvastatin can be decreased when combined with Ertugliflozin.
Amlodipine Amlodipine The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Ertugliflozin.
Itraconazole Itraconazole The serum concentration of Ertugliflozin can be increased when it is combined with Itraconazole.
Lisinopril Lisinopril The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Ertugliflozin is combined with Lisinopril.
Oxaprozin Oxaprozin Ertugliflozin may increase the excretion rate of Oxaprozin which could result in a lower serum level and potentially a reduction in efficacy.
Sotalol Sotalol The risk or severity of hypoglycemia can be increased when Sotalol is combined with Ertugliflozin.
Bisoprolol Bisoprolol The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Bisoprolol.
Isradipine Isradipine Isradipine may increase the excretion rate of Ertugliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Omeprazole Omeprazole Omeprazole may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Fluvastatin Fluvastatin The metabolism of Fluvastatin can be decreased when combined with Ertugliflozin.
Venlafaxine Venlafaxine The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Ertugliflozin.
Fluvoxamine Fluvoxamine The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Ertugliflozin.
Nefazodone Nefazodone The risk or severity of hypoglycemia can be increased when Nefazodone is combined with Ertugliflozin.
Lamotrigine Lamotrigine The metabolism of Lamotrigine can be decreased when combined with Ertugliflozin.
Losartan Losartan The metabolism of Losartan can be decreased when combined with Ertugliflozin.
Valacyclovir Valacyclovir Ertugliflozin may increase the excretion rate of Valaciclovir which could result in a lower serum level and potentially a reduction in efficacy.
Tramadol Tramadol The metabolism of Tramadol can be decreased when combined with Ertugliflozin.
Carboplatin Injection Carboplatin Injection Ertugliflozin may increase the excretion rate of Carboplatin which could result in a lower serum level and potentially a reduction in efficacy.
Moexipril Moexipril The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Ertugliflozin is combined with Moexipril.
Lansoprazole Lansoprazole Lansoprazole may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Ifosfamide Injection Ifosfamide Injection Ertugliflozin may increase the excretion rate of Ifosfamide which could result in a lower serum level and potentially a reduction in efficacy.
Nicardipine Nicardipine The risk or severity of hypoglycemia can be increased when Nicardipine is combined with Ertugliflozin.
Bupropion Bupropion Ertugliflozin may increase the excretion rate of Bupropion which could result in a lower serum level and potentially a reduction in efficacy.
Ticlopidine Ticlopidine Ertugliflozin may increase the excretion rate of Ticlopidine which could result in a lower serum level and potentially a reduction in efficacy.
Saquinavir Saquinavir The serum concentration of Ertugliflozin can be increased when it is combined with Saquinavir.
Nisoldipine Nisoldipine Nisoldipine may increase the excretion rate of Ertugliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Lamivudine Lamivudine Ertugliflozin may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.
Acarbose Acarbose The therapeutic efficacy of Acarbose can be increased when used in combination with Ertugliflozin.
Glimepiride Glimepiride The therapeutic efficacy of Glimepiride can be increased when used in combination with Ertugliflozin.
Gemcitabine Injection Gemcitabine Injection Ertugliflozin may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.
Indinavir Indinavir The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Indinavir.
Ritonavir Ritonavir The serum concentration of Ertugliflozin can be increased when it is combined with Ritonavir.
Cidofovir Injection Cidofovir Injection Ertugliflozin may increase the excretion rate of Cidofovir which could result in a lower serum level and potentially a reduction in efficacy.
Meropenem Injection Meropenem Injection Ertugliflozin may increase the excretion rate of Meropenem which could result in a lower serum level and potentially a reduction in efficacy.
Clomipramine Clomipramine Clomipramine may decrease the hypoglycemic activities of Ertugliflozin.
Fosfomycin Fosfomycin Ertugliflozin may increase the excretion rate of Fosfomycin which could result in a lower serum level and potentially a reduction in efficacy.
Trandolapril Trandolapril The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Ertugliflozin is combined with Trandolapril.
Topiramate Topiramate Ertugliflozin may increase the excretion rate of Topiramate which could result in a lower serum level and potentially a reduction in efficacy.
Insulin Lispro Injection Insulin Lispro Injection The therapeutic efficacy of Insulin lispro can be increased when used in combination with Ertugliflozin.
Pramipexole Pramipexole Ertugliflozin may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.
Nelfinavir Nelfinavir Nelfinavir may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Fexofenadine Fexofenadine The serum concentration of Ertugliflozin can be increased when it is combined with Fexofenadine.
Carvedilol Carvedilol The therapeutic efficacy of Carvedilol can be increased when used in combination with Ertugliflozin.
Nilutamide Nilutamide Ertugliflozin may increase the excretion rate of Nilutamide which could result in a lower serum level and potentially a reduction in efficacy.
Flutamide Flutamide Ertugliflozin may increase the excretion rate of Flutamide which could result in a lower serum level and potentially a reduction in efficacy.
Selegiline Selegiline Selegiline may increase the hypoglycemic activities of Ertugliflozin.
Sertraline Sertraline The risk or severity of hypoglycemia can be increased when Sertraline is combined with Ertugliflozin.
Propafenone Propafenone The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Propafenone.
Raloxifene Raloxifene The metabolism of Raloxifene can be decreased when combined with Ertugliflozin.
Tamsulosin Tamsulosin The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Tamsulosin.
Quetiapine Quetiapine The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Quetiapine.
Cetirizine Cetirizine Ertugliflozin may increase the excretion rate of Cetirizine which could result in a lower serum level and potentially a reduction in efficacy.
Paroxetine Paroxetine The risk or severity of hypoglycemia can be increased when Paroxetine is combined with Ertugliflozin.
Tolcapone Tolcapone Ertugliflozin may increase the excretion rate of Tolcapone which could result in a lower serum level and potentially a reduction in efficacy.
Citalopram Citalopram The risk or severity of hypoglycemia can be increased when Citalopram is combined with Ertugliflozin.
Capecitabine Capecitabine Ertugliflozin may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.
Abacavir Abacavir The metabolism of Abacavir can be decreased when combined with Ertugliflozin.
Sildenafil Sildenafil The serum concentration of Ertugliflozin can be increased when it is combined with Sildenafil.
Pioglitazone Pioglitazone The therapeutic efficacy of Pioglitazone can be increased when used in combination with Ertugliflozin.
Celecoxib Celecoxib The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Celecoxib.
Rosiglitazone Rosiglitazone The therapeutic efficacy of Rosiglitazone can be increased when used in combination with Ertugliflozin.
Tolterodine Tolterodine Ertugliflozin may increase the excretion rate of Tolterodine which could result in a lower serum level and potentially a reduction in efficacy.
Oseltamivir Oseltamivir Ertugliflozin may increase the excretion rate of Oseltamivir which could result in a lower serum level and potentially a reduction in efficacy.
Balsalazide Balsalazide Balsalazide may increase the hypoglycemic activities of Ertugliflozin.
Nateglinide Nateglinide The therapeutic efficacy of Nateglinide can be increased when used in combination with Ertugliflozin.
Rabeprazole Rabeprazole Rabeprazole may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists